Phase II trial of paclitaxel and carboplatin in advanced/metastatic transitional cell cancer

被引：0
|
作者：
Wille, AH
Johannsen, M
Roigas, J
Schnorr, DR
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1422
引用
收藏
页码：380 / 381
页数：2
相关论文
共 50 条
  • [31] Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer
    Gadgeel, SM
    Shields, AF
    Heilbrun, LK
    Labadidi, S
    Zalupski, M
    Chaplen, R
    Philip, PA
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 37 - 41
  • [32] Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer
    Laohavinij, S
    Maoleekoonpairoj, S
    Cheirsilpa, A
    Maneechavakajorn, J
    Sirachainant, E
    Arpornvivat, W
    Jaisathaporn, K
    Ratanatharathorn, V
    [J]. LUNG CANCER, 1999, 26 (03) : 175 - 185
  • [33] A Phase II Trial of Paclitaxel and Carboplatin in Women With Advanced or Recurrent Uterine Carcinosarcoma
    Lacour, Robin A.
    Euscher, Elizabeth
    Atkinson, E. Neely
    Sun, Charlotte C.
    Ramirez, Pedro T.
    Coleman, Robert L.
    Brown, Jubilee
    Gano, Jacalyn B.
    Burke, Thomas W.
    Ramondetta, Lois Michelle
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (03) : 517 - 522
  • [34] A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer
    Kitagawa, Ryo
    Katsumata, Noriyuki
    Ando, Masashi
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Yoshikawa, Hiroyuki
    Satoh, Toyomi
    Nakanishi, Toru
    Ushijima, Kimio
    Kamura, Toshiharu
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 (02) : 307 - 311
  • [35] Phase II Trial of Carboplatin and Paclitaxel in Papillary Renal Cell Carcinoma
    Bylow, Kathryn A.
    Atkins, Michael B.
    Posadas, Edwin M.
    Stadler, Walter M.
    McDermott, David F.
    [J]. CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 39 - 42
  • [36] Phase II trial of carboplatin/paclitaxel and cetuximab, followed by carboplatin/paclitaxel/cetuximab and erlotinib, in metastatic or recurrent squamous cell carcinoma of the head and neck.
    Bhatia, Aarti K.
    Mehra, Ranee
    Khan, Saad A.
    Egleston, Brian L.
    Alpaugh, R. Katherine
    Lango, Miriam
    Ridge, John A.
    Burtness, Barbara
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] PHASE II STUDY OF CARBOPLATIN IN LOCALLY ADVANCED AND METASTATIC TRANSITIONAL CELL-CARCINOMA OF THE URINARY-BLADDER
    RAABE, NK
    FOSSA, SD
    PARO, G
    [J]. BRITISH JOURNAL OF UROLOGY, 1989, 64 (06): : 604 - 607
  • [38] Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
    Tell, Roger
    Sederholm, Christer
    Klintenberg, Claes
    Franksson, Lars
    Branden, Eva
    Hillerdal, Gunnar
    Lonn, Ulf
    Linden, Carl-Johan
    Ewers, Sven-Borje
    Lamberg, Kristina
    Mrazek, Eva
    Loden, Britta
    Sjogren, Anders
    Linne, Thomas
    Friesland, Signe
    Sirzen, Florin
    [J]. ANTICANCER RESEARCH, 2008, 28 (5B) : 2851 - 2857
  • [39] A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer
    Kelly, K
    Mikhaeel-Kamel, N
    Pan, ZX
    Murphy, J
    Prindiville, S
    Bunn, PA
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 (09) : 3474 - 3479
  • [40] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
12345